Kirsten L. White, PhD

Sr. Director
Gilead Sciences, Inc.

Disclosure: Gilead Sciences, Inc. (Individual(s) Involved: Self): Employee, Shareholder

Presentation(s):

• 109 - preexisting Resistance and Week 48 Virologic Outcomes After Switching to B/F/TAF in African American Adults with Hiv

  Oral Abstract